- Home
- ASIX vs DAWN Comparison
ASIX vs DAWN Comparison
Compare ASIX & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASIX
- DAWN
- Stock Information
- Founded
- ASIX 2016
- DAWN 2018
- Country
- ASIX United States
- DAWN United States
- Employees
- ASIX N/A
- DAWN N/A
- Industry
- ASIX Major Chemicals
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- ASIX Industrials
- DAWN Health Care
- Exchange
- ASIX Nasdaq
- DAWN Nasdaq
- Market Cap
- ASIX 561.0M
- DAWN 624.8M
- IPO Year
- ASIX N/A
- DAWN 2021
- Fundamental
- Price
- ASIX $21.11
- DAWN $7.18
- Analyst Decision
- ASIX Buy
- DAWN Strong Buy
- Analyst Count
- ASIX 1
- DAWN 7
- Target Price
- ASIX $32.00
- DAWN $27.86
- AVG Volume (30 Days)
- ASIX 197.9K
- DAWN 999.9K
- Earning Date
- ASIX 10-31-2025
- DAWN 10-29-2025
- Dividend Yield
- ASIX 3.03%
- DAWN N/A
- EPS Growth
- ASIX 829.30
- DAWN N/A
- EPS
- ASIX 2.84
- DAWN N/A
- Revenue
- ASIX $1,515,062,000.00
- DAWN $187,638,000.00
- Revenue This Year
- ASIX $7.41
- DAWN $12.56
- Revenue Next Year
- ASIX $4.60
- DAWN $48.02
- P/E Ratio
- ASIX $7.43
- DAWN N/A
- Revenue Growth
- ASIX 1.31
- DAWN 2190.50
- 52 Week Low
- ASIX $17.97
- DAWN $5.64
- 52 Week High
- ASIX $33.00
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- ASIX 52.38
- DAWN 51.39
- Support Level
- ASIX $20.50
- DAWN $7.03
- Resistance Level
- ASIX $21.85
- DAWN $7.58
- Average True Range (ATR)
- ASIX 0.61
- DAWN 0.28
- MACD
- ASIX 0.10
- DAWN -0.04
- Stochastic Oscillator
- ASIX 49.97
- DAWN 30.80
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.